Product Dossier
APO-DESVENLAFAXINE MR
Product Dossier for APO-DESVENLAFAXINE MR (desvenlafaxine, Arrotex Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Arrotex Pharmaceuticals
- Active ingredient: desvenlafaxine
- Therapeutic area: Psychiatry
- Related brand: DESFAX
- Related brand: PRISTIQ
- Related brand: MEDVEN
- Same area: REXULTI
- Same area: NICORETTE
What it is
APO-DESVENLAFAXINE MR is an extended release tablet containing desvenlafaxine (as benzoate).
Regulatory history
APO-DESVENLAFAXINE MR was first registered on the ARTG on 12 November 2014 in two strengths: 50 mg and 100 mg extended release tablets.